Daxxify vs Botox: The Longer Lasting Option Explained

Daxxify arrived in 2022 with one claim that set it apart from every other wrinkle relaxer: a median duration of about six months in its approval trials, roughly twice the three to four months most patients get from Botox. At Vital Medical Care & Aesthetics we offer both, so the question we hear is not whether Daxxify is real but whether it is right for a particular face.

The direct answer: Daxxify and Botox relax muscles the same way, treat the same frown lines, and have similar side effects on their FDA labels. Daxxify is stabilized with a peptide instead of human albumin and, in trials, held its effect for a median of about six months, with a range on both sides. It suits patients who want fewer visits and who already know they like a relaxed look. Botox remains the better choice for a first trial, for off label areas with a long track record, and for anyone who wants to adjust every few months. Which one you receive is decided at the consultation with Dr. Vital.

What makes Daxxify different: peptide stabilized, no human albumin

Daxxify is daxibotulinumtoxinA, made by Revance and approved by the FDA in 2022 for moderate to severe frown lines, with a second approval in 2023 for cervical dystonia, a neurological neck condition. The active toxin is the same type A molecule found in Botox. What differs is everything around it.

Botox stabilizes its toxin with human serum albumin, a blood derived protein. Daxxify uses a synthetic peptide instead, and the formulation contains no human or animal derived components. The manufacturer attributes the longer duration to that peptide, which is thought to help the toxin bind and stay at the nerve ending; the exact mechanism is still being studied. A practical difference is storage: the powder is stable at room temperature before it is reconstituted. The service is described on our Daxxify page, and Botox treatment on our Botox page.

Duration: what the trials showed versus what patients see

In the two pivotal trials, patients treated with 40 units of Daxxify for frown lines kept a result of none or mild lines for a median of about 24 weeks, and the median time to return to baseline was longer still. A portion of patients held the result for nine months. Botox’s own trials and decades of practice put its typical frown line result at three to four months. The table sets the two side by side, as typical figures from the labels and literature rather than a promise.

Measure	Botox	Daxxify
Label dose, frown lines	20 units	40 units
First visible effect	3 to 5 days	Often 2 to 3 days
Full effect	About 14 days	About 14 days
Median duration in trials	3 to 4 months	About 6 months
Stabilizer	Human albumin	Synthetic peptide
Approved cosmetic areas	Frown lines, forehead, crow’s feet, neck bands	Frown lines

Why the real world number is a range

A median means half of trial patients lasted longer and half shorter. In practice, physicians report that many patients land at four to six months, some reach the trial figure, and a few see little difference from Botox. Dose, muscle strength and the area treated all move the number, exactly as they do for Botox. Our post on how long Botox lasts covers those factors in detail, and they apply to Daxxify as well.

Onset and what you see in the mirror

Daxxify starts quickly. In trials, some patients noticed softening within a day, and most within two to three, which is a little ahead of Botox’s three to five days. Both products reach full effect at about two weeks, which is when the review visit is scheduled.

What you see is the same kind of result: the frown lines no longer deepen when you concentrate, and the skin at rest smooths over the following weeks. Patients who switch sometimes describe the Daxxify result as feeling a little firmer in the first month. That impression is not well measured in the literature, and the dose is planned so that the forehead and brows still move naturally.

Switching from Botox to Daxxify: timing, units and the first time

Switching is straightforward, but it is planned rather than improvised. These are the steps we follow.

1. Let the current Botox wear off. The switch happens at the next cycle, usually three to four months after the last Botox visit, once movement has returned enough to assess the muscle.
2. Convert the dose. Daxxify units are its own scale: the label dose of 40 units for the frown lines corresponds to Botox’s 20, so physicians work from a rough 2 to 1 relationship while treating the dose as a fresh plan. Our Dysport and Botox comparison covers how unit conversion works.
3. Use the full label dose the first time. A lighter trial dose is the most common reason a first Daxxify treatment disappoints, because the duration advantage was measured at 40 units.
4. Review at two weeks. Full effect is in, and any asymmetry or an area that needs a few more units is addressed then.
5. Rebook by the calendar, not by habit. Most patients will not need the usual three month visit, so we set a check at month four or five and treat when movement returns.

The first time is also when to decide which areas go on Daxxify. The frown lines are the approved area. The forehead and crow’s feet are off label for Daxxify, as they were for Botox before its approvals were extended, and some physicians keep those areas on Botox during a first cycle so that the two products can be compared on the same face.

Side effects and safety: what the labels say

The two labels describe similar side effects. For Daxxify in the frown line trials, the common ones were headache in about 6 percent of patients, eyelid droop in about 2 percent, and asymmetry of facial expression in about 1 percent. For Botox the figures in its own trials are headache in roughly 9 percent and eyelid droop in about 2 to 3 percent. Injection site pain, redness and bruising are the everyday effects of both.

Both labels carry the same boxed warning about the rare possibility of toxin effect spreading beyond the injection site, with symptoms such as trouble swallowing, speaking or breathing, or weakness away from the treated area. At cosmetic doses in the face this is rare, and it is still the reason we ask every patient to call the same day if any of those symptoms appear.

One thing to weigh before choosing the longer product

Duration cuts both ways. If a result is heavier than you wanted, it fades on the product’s schedule. An eyelid droop or a flat brow from Daxxify can last longer than the same effect from Botox. That is a reason, not a rule, to try Botox first when you have never had a relaxer.

Reasons to tell the physician

• Pregnancy or breastfeeding: no adequate data for either product, and cosmetic treatment is deferred.
• Neuromuscular conditions such as myasthenia gravis, Lambert Eaton syndrome or ALS.
• Blood thinners, aspirin, fish oil or vitamin E, which raise the chance of bruising.
• A prior reaction to any botulinum toxin product, or an infection at the injection site.

Who it suits, and who should stay on Botox

Daxxify suits a patient who already knows they like the relaxed look, wants two or three visits a year instead of three or four, and has frown lines as the main concern. It also suits anyone who prefers a formulation without human albumin, and people whose schedules make a three month rhythm hard to keep.

Botox remains the better fit for a first relaxer patient who wants a short, reversible trial; for anyone who likes to adjust the dose every few months; for the forehead, crow’s feet and neck bands, where Botox has approvals and the longest record; and for patients treating masseter, lip flip or brow tail areas where Daxxify experience is still building. Patients using Botox for a medical condition should keep that decision with the prescribing physician. None of this is decided from a list. Dr. Vital examines how your face moves, reviews your history with relaxers and recommends one of the four products we offer, including Dysport and Jeuveau, at the consultation.

Cost per treatment versus cost per year

Daxxify usually costs more per treatment than Botox, because the label dose is 40 units on its own scale and the product is priced accordingly. The fairer comparison is the year. A Botox patient on a three to four month schedule has three or four visits; a Daxxify patient who reaches a five or six month result has two or three. When the per treatment difference is modest, the yearly totals often come close, and the Daxxify patient has spent less time in the chair.

Two caveats. If your Daxxify result lands at four months rather than six, the yearly math favors Botox. And a first Daxxify cycle is a test, so plan it as one treatment and decide after the result has run its course. Pricing at Vital Medical Care is confirmed at the consultation once the dose is planned, and the structure is on our price guide.

The consultation at Vital Medical Care

Every relaxer treatment here starts with a consultation. Dr. Vital watches your face move, asks what you want to keep and what you want quiet, reviews medications and medical history, and recommends a product, a dose and a schedule. Candidacy, units and the choice between Daxxify, Botox, Dysport and Jeuveau are all made there, and pregnancy, breastfeeding, neuromuscular conditions and blood thinners are the first things to raise.

Vital Medical Care & Aesthetics is at 2209 Merrick Rd, Suite 202, Merrick, NY 11566, about a ten minute walk from the Merrick LIRR station on the Babylon Branch, with the NICE n19 bus along Merrick Road. Hours are Monday 9am to 5pm, Tuesday 9am to 7pm, Wednesday and Thursday 7:30am to 5pm, Friday 9am to 5pm and Saturday 9am to 2pm. Visits are by appointment: book Daxxify online or call (516) 414-1101.

Questions readers ask

Read next

• Dysport vs Botox: Spread, Onset and Which Areas Suit Each
• Jeuveau vs Botox: What Changes for a First Time Patient
• How Long Botox Lasts, and What Shortens It